Abivax S.A.
ABVX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001956827
No open-market purchases or sales by Abivax S.A. insiders were filed in the last 90 days; 303 institutions reported holding it in 13F filings for Q2 2026, worth $7.18B in total; Maverick Capital is the only superinvestor holding it.
Other share classesAAVXF
13F holders, Q3 2024
Institutional positions in Abivax S.A. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- +2 vs. Q2 2024
- Shares held
- 27.4M
- −715.0K (−2.5%) vs. Q2 2024
- Total value
- $312.8M
- −$58.8M (−15.8%) vs. Q2 2024
- New holders
- 4
- 17 more added
- Sold out
- 2
- 11 more reduced
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ABVX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 303 | $7.18B |
| Q1 2026 | 254 | $5.53B |
| Q4 2025 | 247 | $7.61B |
| Q3 2025 | 165 | $4.41B |
| Q2 2025 | 43 | $234.6M |
| Q1 2025 | 46 | $198.5M |
| Q4 2024 | 48 | $218.6M |
| Q3 2024 | 40 | $312.8M |
| Q2 2024 | 38 | $371.6M |
| Q1 2024 | 36 | $334.2M |
| Q4 2023 | 30 | $227.8M |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Abivax S.A.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Principal Securities, Inc. | 10 | $115 | 0.00% | +10 | New |
| Advisor Group Holdings, Inc. | 32 | $369 | 0.00% | +26+433.3% | Added |
| Financial Management Professionals, Inc. | 100 | $1.00K | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 684 | $7.88K | 0.00% | +90+15.2% | Added |
| UBS Group AG | 691 | $7.96K | 0.00% | +691 | New |
| Bank of America Corp | 3,546 | $40.8K | 0.00% | +727+25.8% | Added |
| HighTower Advisors, LLC | 10,000 | $115.0K | 0.00% | 00.0% | Unchanged |
| Caxton Corp | 11,365 | $130.9K | 0.54% | −2,535−18.2% | Reduced |
| BNP Paribas Arbitrage, SA | 13,044 | $150.3K | 0.00% | +5,900+82.6% | Added |
| Geode Capital Management, LLC | 15,572 | $179.4K | 0.00% | +1,183+8.2% | Added |
| Cubist Systematic Strategies, LLC | 16,453 | $189.5K | 0.00% | +10,426+173.0% | Added |
| Marshall Wace, LLP | 30,910 | $356.1K | 0.00% | +30,910 | New |
| Polar Asset Management Partners Inc. | 34,939 | $402.5K | 0.01% | −18,300−34.4% | Reduced |
| HighVista Strategies LLC | 49,064 | $565.2K | 0.19% | −445−0.9% | Reduced |
| Woodline Partners LP | 81,730 | $941.5K | 0.01% | +50,446+161.3% | Added |
| Atika Capital Management LLC | 113,631 | $1.31M | 0.14% | −57,006−33.4% | Reduced |
| Soleus Capital Management, L.P. | 125,000 | $1.44M | 0.12% | +125,000 | New |
| Rosalind Advisors, Inc. | 139,983 | $1.61M | 1.07% | −238,433−63.0% | Reduced |
| Kennedy Capital Management, Inc. | 223,814 | $2.58M | 0.06% | +91,783+69.5% | Added |
| Walleye Capital LLC | 257,417 | $2.97M | 0.03% | +80,807+45.8% | Added |
| Standard Life Aberdeen plc | 316,431 | $3.65M | 0.01% | +198,225+167.7% | Added |
| Janus Henderson Group PLC | 410,710 | $4.74M | 0.00% | −764,804−65.1% | Reduced |
| Silverarc Capital Management, LLC | 461,660 | $5.32M | 1.20% | +5,860+1.3% | Added |
| Citadel Advisors LLC | 466,429 | $5.37M | 0.01% | +11,669+2.6% | Added |
| Morgan Stanley | 504,752 | $5.81M | 0.00% | −58,801−10.4% | Reduced |
| ADAR1 Capital Management, LLC | 521,612 | $6.01M | 1.01% | +494,612+1,831.9% | Added |
| Adage Capital Partners GP, L.L.C. | 530,861 | $6.12M | 0.01% | +5,861+1.1% | Added |
| Point72 Asset Management, L.P. | 542,900 | $6.25M | 0.02% | +119,300+28.2% | Added |
| Millennium Management LLC | 645,637 | $7.44M | 0.01% | +568,035+732.0% | Added |
| Saturn V Capital Management LLC | 648,019 | $7.47M | 2.67% | +20,259+3.2% | Added |
| Samsara BioCapital, LLC | 850,000 | $9.79M | 1.88% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 985,634 | $11.4M | 0.96% | 00.0% | Unchanged |
| Franklin Resources Inc | 1,324,352 | $12.6M | 0.00% | −70,700−5.1% | Reduced |
| Commodore Capital LP | 1,284,110 | $14.8M | 0.92% | 00.0% | Unchanged |
| VR Adviser, LLC | 1,345,780 | $15.5M | 0.81% | 00.0% | Unchanged |
| Blackstone Group Inc. | 1,522,434 | $17.5M | 0.08% | −339,603−18.2% | Reduced |
| Great Point Partners LLC | 2,128,773 | $24.5M | 7.40% | −343,415−13.9% | Reduced |
| Cormorant Asset Management, LP | 2,130,000 | $24.5M | 1.30% | 00.0% | Unchanged |
| Deep Track Capital, LP | 3,579,209 | $41.2M | 1.32% | −600,554−14.4% | Reduced |
| TCG Crossover Management, LLC | 6,056,596 | $69.8M | 5.91% | 00.0% | Unchanged |
| Options Solutions, LLC | 0 | $0 | 0.00% | −34,750−100.0% | Sold out |
| Sandia Investment Management LP | 0 | $0 | 0.00% | −7,500−100.0% | Sold out |